|
|
| Line 18: |
Line 18: |
|
| |
|
| </StructureSection> | | </StructureSection> |
| ==3D structures of protein kinase C==
| |
|
| |
|
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| |
| {{#tree:id=OrganizedByTopic|openlevels=0|
| |
|
| |
| *'''Conventional PKCs'''
| |
|
| |
| *PKC-α
| |
|
| |
| **[[2eli]] – hCPKC-α C1 domain – human – NMR<br />
| |
| **[[4dnl]] - hCPKC-α C2 domain<br />
| |
| **[[3iw4]], [[4ra4]] - hCPKC-α kinase domain + inhibitor<br />
| |
| **[[1dsy]], [[3rdj]], [[3twy]], [[2nce]] – rCPKC-α C2 domain – rat
| |
|
| |
| **[[4l1l]] - rCPKC-α C2 domain + ion<br />
| |
| **[[5w4s]] - rCPKC- C2 domain + peptide<br />
| |
|
| |
| **[[3gpe]] - rCPKC-α C2 domain + Ca + PTDINS
| |
|
| |
| *PKC-β
| |
|
| |
| **[[1a25]] – rCPKC-β C2 domain<br />
| |
| **[[3pfq]] - rCPKC-b II<br />
| |
|
| |
| *PKC-β2
| |
|
| |
| **[[2i0e]] - hCPKC-β2 catalytic domain
| |
|
| |
| **[[3pfq]] - rCPKC-β2 (mutant)
| |
|
| |
| *PKC-γ
| |
|
| |
| **[[2uzp]] - hCPKC-γ C2 domain
| |
|
| |
| **[[2e73]] - hCPKC-γ C1 domain - NMR
| |
|
| |
| **[[1tbn]], [[1tbo]] - rCPKC-γ C2 domain – NMR<br />
| |
|
| |
| *'''Novel PKC'''
| |
|
| |
| *PKC-δ
| |
|
| |
| **[[1yrk]] – hNPKC-δ C2 domain + peptide
| |
|
| |
| **[[2yuu]] - hNPKC-δ C1 domain - NMR
| |
|
| |
| **[[2coa]] - hNPKC-δ PH domain – NMR<br />
| |
| **[[1ptq]] – mNPKC-δ C2 domain – mouse<br />
| |
| **[[3uej]] - mNPKC-δ C1B domain<br />
| |
| **[[3uey]], [[3uff]], [[3ugd]], [[3ugi]], [[3ugl]] - mNPKC-δ C1B domain (mutant)<br />
| |
|
| |
| **[[1ptr]] - mNPKC-δ C2 domain + phorbol-acetate
| |
|
| |
| **[[1bdy]] - rNPKC-δ C2 domain
| |
|
| |
| *PKC-ε
| |
|
| |
| **[[1gmi]] – rNPKC-ε C2 domain
| |
|
| |
| *PKC-η
| |
|
| |
| **[[2fk9]] – hNPKC-η C2 domain<br />
| |
| **[[3txo]] - hNPKC-η kinase domain (mutant) + inhibitor<br />
| |
|
| |
| *PKC-θ
| |
|
| |
| **[[4fkd]] – hNPKC-θ second Cys-rich regulatory domain<br />
| |
| **[[2enj]] - hNPKC-θ C2 domain – NMR
| |
|
| |
| **[[2enn]], [[2enz]] - hNPKC-θ C1 domain – NMR
| |
|
| |
| **[[1xjd]] – hNPKC-θ + saurosporine
| |
|
| |
| **[[2jed]], [[4q9z]], [[5f9e]], [[4ra5]] - hNPKC-θ kinase domain + inhibitor
| |
|
| |
| *'''Atypical PKC'''
| |
|
| |
| *PKC-ι; domains – PB1 16-99; kinase 249-588
| |
|
| |
| **[[1vd2]] – hAPKC-ι PB1 domain – NMR<br />
| |
| **[[1wmh]] - hAPKC-ι PB1 domain + PAR6 alpha<br />
| |
| **[[3a8w]], [[3a8x]], [[1zrz]] - hAPKC-ι kinase domain<br />
| |
| **[[6ilz]] - hAPKC-ι kinase domain + inhibitor<br />
| |
| **[[3zh8]] - hAPKC-ι kinase domain (mutant) + inhibitor<br />
| |
| **[[1wmh]] - hAPKC-ι PB1 domain + PAR6 alpha<br />
| |
| **[[4dc2]] - hAPKC-ι kinase domain + PAR3 peptide<br />
| |
| **[[5lih]] - hAPKC-ι kinase domain + PKC-εζ peptide<br />
| |
|
| |
| *PKC-ν
| |
|
| |
| **[[2d9z]] – hPKC-ν PH domain - NMR
| |
|
| |
| *PKC-ζ
| |
|
| |
| **[[4mjs]] - rPKC-ζ + sequestosome-1<br />
| |
| }}
| |
| == References == | | == References == |
| <references/> | | <references/> |
| [[Category:Topic Page]] | | [[Category:Topic Page]] |